Related Experiment Video

Updated: Jun 4, 2026

Cytosolic Calcium Measurements in Renal Epithelial Cells by Flow Cytometry
10:24

Cytosolic Calcium Measurements in Renal Epithelial Cells by Flow Cytometry

Published on: October 28, 2014

Use of calcium ion entry blockers in family practice

P H Tanser

    Canadian Family Physician Medecin De Famille Canadien
    |February 2, 2011
    PubMed

    Insights

    Verapamil, nifedipine, and diltiazem are calcium channel blockers that treat various cardiovascular conditions. They differ in their specific actions and therapeutic uses, offering distinct treatment options for patients.

    Area of Science:

    • Pharmacology
    • Cardiovascular Medicine

    Background:

    • Verapamil, nifedipine, and diltiazem are calcium channel blockers.
    • These drugs decrease intracellular calcium in cardiac muscle, smooth muscle, and nodal cardiac cells.
    • Each drug acts at a different site on the cell membrane, leading to distinct overall actions compared to beta-blockers.

    Purpose of the Study:

    • To outline the distinct mechanisms and therapeutic applications of verapamil, nifedipine, and diltiazem.
    • To differentiate the roles of these calcium channel blockers from beta-blockers.
    • To highlight the established and emerging uses of these cardiovascular drugs.

    Main Methods:

    • Review of pharmacological actions of verapamil, nifedipine, and diltiazem.
    • Analysis of clinical applications for systemic hypertension, angina, and arrhythmias.
    • Comparison of drug mechanisms at the cellular level.

    Main Results:

    • Verapamil is indicated for angina, systemic hypertension, hypertrophic cardiomyopathy, and supraventricular and junctional tachyarrhythmias.
    • Nifedipine is effective for angina, vasospastic disorders, and hypertension.
    • The specific clinical role for diltiazem is currently being defined.

    Conclusions:

    • Verapamil, nifedipine, and diltiazem represent a class of drugs with diverse cardiovascular applications.
    • Understanding their distinct mechanisms of action is crucial for optimal patient treatment.
    • Further research is defining the precise therapeutic niche for diltiazem.

    More Related Videos

    Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli12:19

    Single-channel Analysis and Calcium Imaging in the Podocytes of the Freshly Isolated Glomeruli

    Published on: June 27, 2015

    Related Concept Videos

    Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

    Antihypertensive Drugs: Action of Calcium Channel Blockers

    Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
    Antiepileptic Drugs: Calcium Channel Blockers01:17

    Antiepileptic Drugs: Calcium Channel Blockers

    Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
    Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
    Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

    Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

    Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
    Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
    Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

    Antianginal Drugs: Calcium Channel Blockers and Ranolazine

    Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
    CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
    Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

    Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

    Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
    Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
    Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers01:12

    Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers

    Class III antiarrhythmic drugs are a group of medications that can prolong action potentials in the heart. They achieve this by blocking potassium channels or enhancing inward currents from sodium channels. However, these drugs have a unique property of "reverse use-dependence," which is most pronounced at slower heart rates and can lead to torsades de pointes—a specific type of arrhythmia. However, it is essential to note that excessive QT interval prolongation—a measure of the heart's...